Retapamulin
Edina Avdic, Pharm.D.
,
Paul A. Pham, Pharm.D. BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Indicated for the topical treatment of
impetigo
due to
S. aureus
(MSSA) or
S. pyogenes
in patients >9 months old.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
In vitro
activity against MRSA, but no clinical data.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.